DK1593690T3 - Fremstilling af ScFv-antistoffragmenter - Google Patents
Fremstilling af ScFv-antistoffragmenterInfo
- Publication number
- DK1593690T3 DK1593690T3 DK04010702T DK04010702T DK1593690T3 DK 1593690 T3 DK1593690 T3 DK 1593690T3 DK 04010702 T DK04010702 T DK 04010702T DK 04010702 T DK04010702 T DK 04010702T DK 1593690 T3 DK1593690 T3 DK 1593690T3
- Authority
- DK
- Denmark
- Prior art keywords
- antibody fragments
- preparation
- scfv antibody
- methods
- invention further
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/243—Colony Stimulating Factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04010702A EP1593690B1 (en) | 2004-05-05 | 2004-05-05 | Preparation of ScFv antibody fragments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1593690T3 true DK1593690T3 (da) | 2009-11-09 |
Family
ID=34924877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04010702T DK1593690T3 (da) | 2004-05-05 | 2004-05-05 | Fremstilling af ScFv-antistoffragmenter |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US8247194B2 (da) |
| EP (2) | EP1593690B1 (da) |
| AT (1) | ATE435238T1 (da) |
| AU (1) | AU2005238203B2 (da) |
| CA (1) | CA2562604C (da) |
| DE (1) | DE602004021773D1 (da) |
| DK (1) | DK1593690T3 (da) |
| WO (1) | WO2005105844A2 (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE435238T1 (de) * | 2004-05-05 | 2009-07-15 | Micromet Ag | Herstellung eines einkettigen fv antikörperfragments |
| MX2007012569A (es) * | 2005-04-18 | 2007-12-06 | Micromet Ag | Neutralizadores de anticuerpos del factor estimulante de la colonia de macrofagos-granulocitos humanos. |
| ES2918209T3 (es) | 2005-05-18 | 2022-07-14 | Morphosys Ag | Anticuerpos anti-GM-CSF y usos a partir de los mismos |
| JP4736037B2 (ja) * | 2005-10-26 | 2011-07-27 | 株式会社イーベック | ヒトgm−csfに結合するヒトのモノクローナル抗体並びにその抗原結合部分 |
| AU2013201228B2 (en) * | 2006-02-08 | 2016-01-21 | Eisai, Inc. | Antigenic gm-csf peptides and antibodies to gm-csf |
| KR101395515B1 (ko) | 2006-02-08 | 2014-05-14 | 모르포테크, 인크. | 항원성 gm-csf 펩티드 및 gm-csf에 대한 항체 |
| AR064333A1 (es) | 2006-12-14 | 2009-04-01 | Schering Corp | Anticuerpo anti-tslp de diseno |
| TW200918553A (en) * | 2007-09-18 | 2009-05-01 | Amgen Inc | Human GM-CSF antigen binding proteins |
| US8679502B2 (en) | 2007-11-13 | 2014-03-25 | Evec Inc. | Monoclonal antibodies that bind to HGM-CSF and medical compositions comprising same |
| US8840890B2 (en) * | 2008-11-12 | 2014-09-23 | University Of Maryland, Baltimore | Rapid expression cloning of human monoclonal antibodies from memory B cells |
| EP3381471B1 (en) | 2008-12-22 | 2024-03-20 | The University of Melbourne | Pain treatment |
| DK2376121T4 (da) | 2008-12-22 | 2021-08-16 | Univ Melbourne | Slidgigtbehandling |
| EP3594356A1 (en) | 2009-11-04 | 2020-01-15 | Merck Sharp & Dohme Corp. | Engineered anti-tslp antibody |
| WO2014004549A2 (en) | 2012-06-27 | 2014-01-03 | Amgen Inc. | Anti-mesothelin binding proteins |
| US9833410B2 (en) | 2012-10-31 | 2017-12-05 | Takeda Gmbh | Lyophilized formulation comprising GM-CSF neutralizing compound |
| AR093297A1 (es) | 2012-10-31 | 2015-05-27 | Amgen Res Munich Gmbh | Formulacion liquida que comprende un compuesto neutralizante de gm-csf |
| RU2714919C2 (ru) | 2013-08-30 | 2020-02-21 | Такеда Гмбх | Антитела, нейтрализующие gm-csf, для применения в лечении ревматоидного артрита или в качестве анальгетиков |
| MX2016017393A (es) | 2014-07-01 | 2017-09-05 | Pfizer | Diacuerpos heterodimericos biespecificos y sus usos. |
| CA3064375A1 (en) * | 2017-05-25 | 2018-11-29 | Memorial Sloan Kettering Cancer Center | Use of the il-15/il-15ra complex in the generation of antigen-specific t cells for adoptive immunotherapy |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6265150B1 (en) * | 1995-06-07 | 2001-07-24 | Becton Dickinson & Company | Phage antibodies |
| ATE435238T1 (de) * | 2004-05-05 | 2009-07-15 | Micromet Ag | Herstellung eines einkettigen fv antikörperfragments |
-
2004
- 2004-05-05 AT AT04010702T patent/ATE435238T1/de active
- 2004-05-05 DE DE602004021773T patent/DE602004021773D1/de not_active Expired - Lifetime
- 2004-05-05 DK DK04010702T patent/DK1593690T3/da active
- 2004-05-05 EP EP04010702A patent/EP1593690B1/en not_active Expired - Lifetime
-
2005
- 2005-05-04 US US11/568,685 patent/US8247194B2/en active Active
- 2005-05-04 CA CA2562604A patent/CA2562604C/en not_active Expired - Lifetime
- 2005-05-04 EP EP05743231A patent/EP1742967A2/en not_active Withdrawn
- 2005-05-04 AU AU2005238203A patent/AU2005238203B2/en not_active Expired
- 2005-05-04 WO PCT/EP2005/004893 patent/WO2005105844A2/en not_active Ceased
-
2012
- 2012-08-17 US US13/588,678 patent/US9279017B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ATE435238T1 (de) | 2009-07-15 |
| DE602004021773D1 (de) | 2009-08-13 |
| AU2005238203A1 (en) | 2005-11-10 |
| CA2562604C (en) | 2014-02-18 |
| US8247194B2 (en) | 2012-08-21 |
| WO2005105844A3 (en) | 2006-01-26 |
| AU2005238203B2 (en) | 2010-09-02 |
| US9279017B2 (en) | 2016-03-08 |
| EP1593690B1 (en) | 2009-07-01 |
| US20080193978A1 (en) | 2008-08-14 |
| US20130171165A1 (en) | 2013-07-04 |
| EP1742967A2 (en) | 2007-01-17 |
| WO2005105844A2 (en) | 2005-11-10 |
| CA2562604A1 (en) | 2005-11-10 |
| EP1593690A1 (en) | 2005-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004021773D1 (de) | Herstellung eines einkettigen fv Antikörperfragments | |
| NO2017032I1 (no) | bezlotoksumab | |
| EA200702008A1 (ru) | Антитела-нейтрализаторы гранулоцитарно-макрофагального колониестимулирующего фактора человека | |
| WO2008097817A3 (en) | Multivariable antigens complexed with targeting humanized monoclonal antibody | |
| WO2007129895A3 (en) | Deimmunized antagonistic anti-human cd40 monoclonal antibody from the ch5d12 antibody | |
| HRP20181218T1 (hr) | Humanizirana anti-il-6 protutijela, pripravci, postupci pripreme i upotrebe | |
| WO2008027236A3 (en) | Multispecific antibodies | |
| CY1118343T1 (el) | Αντισωματα συνδεσης twεακ | |
| WO2009036209A3 (en) | Homogeneous antibody populations | |
| DK3421498T3 (da) | Monoklonale antistoffer mod claudin-18 til behandling af cancer | |
| LTC2041177I2 (lt) | Didelio giminingumo antikūnai prieš žmogaus IL-6 receptorių | |
| BRPI0821211A2 (pt) | Anticorpo anti-humano cd34 humanizado, o método de preparação e usos do mesmo. | |
| RU2018119686A (ru) | Антитела и фрагменты антител для сайт-специфического конъюгирования | |
| WO2007008943A3 (en) | Optimized anti-ep-cam antibodies | |
| WO2009112245A9 (en) | Antibody against the csf-1 r | |
| CR10563A (es) | Anticuerpos monoclonales ant-il-6 y usos de los mismos | |
| BRPI0908508A2 (pt) | anticorpo monoclonal nkg2a anti-humano humanizado | |
| EA200802168A1 (ru) | Гуманизированное антитело к с-kit | |
| WO2010042562A3 (en) | Muc1* antibodies | |
| IL197459A0 (en) | Humanized proteins, including antibodies and methods for producing the same | |
| TR201901841T4 (tr) | Her antikorlarının sabit dozlaması. | |
| EA200900492A1 (ru) | Молекулы антител, которые связываются с il-17a и il-17f | |
| CR8958A (es) | Anticuerpos Anti-5T4 humanizados y conjugados de anticuerpos anti-5T4/caliqueamicina | |
| CR11079A (es) | Anticuerpos contra il-25 | |
| MX2010001237A (es) | Nuevos anticuerpos. |